CC
ARIA

Curian Capital’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Curian Capital’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-62,606
Closed -$427K – 658
2013
Q4 		$427K Buy
62,606
+63
+0.1% +$340 0.01% 512
2013
Q3 		$1.15M Buy
62,543
+1,030
+2% +$20K 0.02% 358
2013
Q2 		$1.08M Buy
+61,513
New +$1.09M 0.02% 353

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Curian Capital's ARIA Position: Q1 2014 in Review

Curian Capital sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2014, closing a stake of 62,606 shares — an estimated $427K sold.

Curian Capital first reported a position in ARIA in Q2 2013 and held it in 3 quarters. The position peaked at $1.15M in Q3 2013. 171 funds tracked by Wall St. Rank hold ARIA as of Q1 2014.

  • Curian Capital reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2014 after selling out during the quarter.
  • Curian Capital sold 62,606 Ariad Pharmaceuticals Inc shares in Q1 2014, an estimated $427K.
  • Curian Capital first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • Curian Capital's Ariad Pharmaceuticals Inc position peaked at $1.15M in Q3 2013.
  • 171 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2014.

Based on Curian Capital's 13F filing for Q1 2014, filed 12 May 2014.